Finally Heard – Cyber Help for Small Businesses is on Its Way
Client Alert | 1 min read | 08.22.18
New cybersecurity legislation was recently passed that aims to help smaller government contractors in their efforts to safeguard sensitive customer data. The NIST Small Business Cybersecurity Act requires the National Institute of Standards and Technology (NIST) to issue guidance and resources, within the next year, to help small- and medium-sized businesses identify, assess, and reduce cybersecurity risks. Partly in response to the rising number of cyberattacks targeting small businesses, the legislation is the latest in a series of efforts more broadly focused on supply chain security throughout the procurement process. Under the Act, NIST must also:
- Ensure future resources can vary with the nature and size of the small business, as well as the nature and sensitivity of the data handled.
- Encourage the use of technology neutral, commercial off-the-shelf (COTS) solutions.
- Promote awareness of basic controls, a workplace cybersecurity culture, and third-party stakeholder relationships.
Contacts
Partner and Crowell Global Advisors Senior Director
- Washington, D.C.
- D | +1.202.624.2698
- Washington, D.C. (CGA)
- D | +1 202.624.2500
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
